- Home
- OST vs XNCR Comparison
OST vs XNCR Comparison
Compare OST & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- XNCR
- Stock Information
- Founded
- OST 2010
- XNCR 1997
- Country
- OST China
- XNCR United States
- Employees
- OST N/A
- XNCR N/A
- Industry
- OST Industrial Machinery/Components
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- OST Technology
- XNCR Health Care
- Exchange
- OST Nasdaq
- XNCR Nasdaq
- Market Cap
- OST 601.6M
- XNCR 579.3M
- IPO Year
- OST 2022
- XNCR 2013
- Fundamental
- Price
- OST $0.13
- XNCR $8.23
- Analyst Decision
- OST
- XNCR Buy
- Analyst Count
- OST 0
- XNCR 7
- Target Price
- OST N/A
- XNCR $27.50
- AVG Volume (30 Days)
- OST 23.2M
- XNCR 800.2K
- Earning Date
- OST 08-25-2025
- XNCR 08-04-2025
- Dividend Yield
- OST N/A
- XNCR N/A
- EPS Growth
- OST N/A
- XNCR N/A
- EPS
- OST N/A
- XNCR N/A
- Revenue
- OST $38,333,251.00
- XNCR $127,228,000.00
- Revenue This Year
- OST N/A
- XNCR N/A
- Revenue Next Year
- OST N/A
- XNCR $28.84
- P/E Ratio
- OST N/A
- XNCR N/A
- Revenue Growth
- OST N/A
- XNCR N/A
- 52 Week Low
- OST $0.13
- XNCR $7.16
- 52 Week High
- OST $9.40
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- OST 25.45
- XNCR 39.25
- Support Level
- OST $6.07
- XNCR $7.88
- Resistance Level
- OST $6.91
- XNCR $8.80
- Average True Range (ATR)
- OST 1.14
- XNCR 0.49
- MACD
- OST -0.38
- XNCR -0.09
- Stochastic Oscillator
- OST 0.45
- XNCR 9.33
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.